Advertisement

Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis

Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis

Int J Artif Organs 2016; 39(12): 603 - 610

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.5301/ijao.5000549

Authors

Kuo-Ching Yuan, Shang-Yu Wang, Ming-Chin Yu, Yu-Pao Hsu, Heng-Chih Pan, Yung-Chang Chen

Abstract

Introduction

Severe sepsis and septic shock is still a challenge. Polymyxin B hemoperfusion (PMX) is a device designed to remove circulating endotoxin by adsorption, which is reported to improve treatment outcomes. This study aimed to further verify the efficacy of PMX on postoperative, peritonitis, septic shock patients.

Methods

This study prospectively analyzed 20 of 155 patients who presented with postoperative septic shock and were treated with PMX in a single institute during the period March 2013 to September 2014 (Clinical Trial Protocol number: ChiCTR-ONC-16008160). A control group (53 patients) was recruited from our own 2012 database using the propensity-matching score method. The data collection includes demographic data, postoperative organ dysfunction status, disease severity and treatment result.

Results

The 2 groups (treatment vs. control) were similar in demographic data, organ dysfunction status and disease severity. PMX use provides benefits for recovery of hemodynamic status and many other aspects, including better survival, but is not statistically significant. For survival factor analysis, PMX use is also not significant for patient survival in our study.

Conclusions

PMX provided some benefits to patients in the treatment for peritonitis septic shock. An improvement in hemodynamic status was mostly observed. Our study also supports the finding that PMX used as an auxiliary treatment provides improved survival but is not statistically significant, possibly due to the small sample size with multiple comorbidities.

Article History

Disclosures

Financial support: This study was supported by grants from Chang Gung Memorial Hospital Research Program (CMRPG3B1871).
Conflict of interest: The authors declare that they have no competing financial or nonfinancial interests.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  •  Division of Trauma and Emergency Surgery, Department of Surgery, Chang-Gung Memorial Hospital, Taipei - Taiwan
  •  Division of General Surgery, Department of Surgery, Chang-Gung Memorial Hospital, Taipei - Taiwan
  •  Division of Nephrology, Department of Medicine, Keelung Chang Gung Memorial Hospital, Keelung City - Taiwan
  •  Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taipei - Taiwan
  •  Chang Gung University College of Medicine, Taoyuan - Taiwan

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.